Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylcysteine versus tranexamic acid versus placebo for occult blood loss in knee arthroplasty
IRCT20241023063471N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in knee osteoarthritis (OA) comparing Tranexamic acid, Acetylcysteine and Placebo normal saline (3 arms). Primary endpoints: Hidden bleeding and Clinical outcomes. Started Dec 2024; status: completed.
02
Drugs
acetylcysteinetranexamic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20241023063471N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241023063471N1.